Literature DB >> 7036643

Presence of specific antigens in neuronal cells infected with fixed and street rabies virus strains.

H Tsiang, J C Guillon.   

Abstract

The presence of rabies specific antigens is investigated after infection with different rabies virus strains in neural cell lines and in the central nervous system of laboratory rodents. In fixed rabies infected cells, the rabies glycoprotein is found to be present 48 h after infection, whereas in hamsters this protein was found 5 days after an intracerebral inoculation. In contrast, rabies glycoprotein was not detectable in any of the street rabies-infected cell system by the fluorescent antibody test, although nucleoprotein was present, showing that infection occurred in these cells. Rabies glycoprotein was also undetectable in the central nervous system (CNS) of athymic nude mice which is known to be very sensitive to street rabies infection and to contain large quantities of viral material. Our results suggest that the smaller amount of rabies glycoprotein synthesized during street rabies infection are of consequence for the pathogenesis of rabies disease. The immunopathology of street rabies virus infection is certainly modulated by the failure of the viral glycoprotein to be present in large quantities on the surface of the infected cellular membrane as in the case of fixed rabies.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7036643     DOI: 10.1007/bf00690988

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  11 in total

1.  [Rabies anti-glycoprotein IgG conjugated with peroxidase and fluorescein isothiocyanate (author's transl)].

Authors:  P Atanasiu; H Tsiang; P Perrin; S Favre
Journal:  Ann Microbiol (Paris)       Date:  1975 Jul-Aug

2.  Rabies pathogenesis.

Authors:  F A Murphy
Journal:  Arch Virol       Date:  1977       Impact factor: 2.574

3.  Rabies virus infection selectively impairs membrane receptor functions in neuronal model cells.

Authors:  K Koschel; M Halbach
Journal:  J Gen Virol       Date:  1979-03       Impact factor: 3.891

4.  Antigenic properties of rabies virus components.

Authors:  T J Wiktor; E György; D Schlumberger; F Sokol; H Koprowski
Journal:  J Immunol       Date:  1973-01       Impact factor: 5.422

5.  [Extraction of a soluble antigen (a glycoprotein) from rabies tissue culture vaccines using Triton X100. Immunization and protection experiments (author's transl)].

Authors:  P Atanasiu; H Tsiang; P Perrin; S Favre; J Sisman
Journal:  Ann Microbiol (Paris)       Date:  1974-12

6.  Use of hybridoma monoclonal antibodies in the detection of antigenic differences between rabies and rabies-related virus proteins. II. The glycoprotein.

Authors:  A Flamand; T J Wiktor; H Koprowski
Journal:  J Gen Virol       Date:  1980-05       Impact factor: 3.891

7.  Rabies antigens in Purkinje cells and granular cells separated from infected cerebellum.

Authors:  H Tsiang
Journal:  Ann Microbiol (Paris)       Date:  1977-10

8.  Experimental rabies in skunks: immunofluorescence light and electron microscopic studies.

Authors:  K M Charlton; G A Casey
Journal:  Lab Invest       Date:  1979-07       Impact factor: 5.662

9.  In vivo detection of specific cell-mediated immunity in street rabies virus infection in mice.

Authors:  H Tsiang; P H Lagrange
Journal:  J Gen Virol       Date:  1980-03       Impact factor: 3.891

10.  Suppression of cell-mediated immunity by street rabies virus.

Authors:  T J Wiktor; P C Doherty; H Koprowski
Journal:  J Exp Med       Date:  1977-06-01       Impact factor: 14.307

View more
  2 in total

1.  The distribution of Challenge virus standard rabies virus versus skunk street rabies virus in the brains of experimentally infected rabid skunks.

Authors:  N L Smart; K M Charlton
Journal:  Acta Neuropathol       Date:  1992       Impact factor: 17.088

2.  Rabies virus infection of cultured rat sensory neurons.

Authors:  E Lycke; H Tsiang
Journal:  J Virol       Date:  1987-09       Impact factor: 5.103

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.